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Introduction
Objective biomarkers of diet have the potential to reduce bias and error relative to self-reported measures, and thus better detect associations between specific dietary factors and health (1, 2) . Our group has been developing objective biomarkers of dietary intake based on stable isotope ratios for use in ongoing research to improve the health of the YupÕik people in southwest Alaska (3) (4) (5) (6) . We have shown that RBCs and hair nitrogen isotope ratios ( 15 N/ 14 N, expressed as d 15 N, as defined in Participants and Methods) are strongly correlated (>0.8) with the RBC long-chain n-3 PUFAs EPA and DHA because all 3 measures are elevated in fish and marine mammals, a large component of the traditional YupÕik diet (5) (6) (7) . Intakes of EPA and DHA are high and quite variable in YupÕik people (6) ; therefore, associations with health are of particular interest for further study (8) (9) (10) (11) . Because d 15 N is relatively simple and inexpensive to assay, several recent studies have used d 15 N as a surrogate measure of n-3 PUFA intake (10, 12, 13) . However, EPA and DHA derive from marine fats, whereas elevated d 15 N derives from marine protein, and these components are sometimes rendered and eaten separately (e.g., as seal oil and seal meat). The nutrients in the fat and lean components of the marine diet may also have different biologic effects, and thus may exhibit different associations with chronic disease risk. For these reasons, the validity of using d 15 N to assess associations between n-3 PUFA intake and chronic disease risk needs to be tested.
This study had 2 objectives. The first was to further extend our evaluation of the use of d 15 N to assess EPA and DHA intake in a YupÕik population by comparing associations with chronic disease risk factors among RBC EPA, DHA, and d 15 N. These risk factors include measures of blood pressure, blood lipids, blood sugar homeostasis, growth factors, inflammatory biomarkers, and adipokines, which were previously described in a YupÕik population by our group (8, 9) . To these, we added 3 measures of obesity (BMI, waist circumference, and percentage of body fat) (14) , glycosylated hemoglobin A1c (HbA1c) 9 (15) , and grehlin (16) , as is detailed in the Participants and Methods section. Previously, we showed that RBC EPA and DHA are associated with reduced triglyceride and C-reactive protein (CRP) concentrations and increased HDL cholesterol in this population (9) . Replication of findings based on RBC FAs is an important criterion when considering using d 15 N as a biomarker of EPA and DHA intake (17) . Because both percentage of RBC EPA and d
15 N increase linearly with marine food intake, whereas percentage of RBC DHA approaches an upper boundary at higher intakes (6, 18) , we expected associations with chronic disease risk factors to be strongest for EPA and d 15 N, and weaker for DHA. Our second objective was to use d 15 N to examine associations between marine food intake and both obesity and risk factors for chronic disease in a larger population sample, from which only d 15 N measures were available.
Participants and Methods
Participant recruitment and procedures. Data are from the Center for Alaska Native Health Research (CANHR) study, a cross-sectional, community-based participatory research study of biologic, genetic, nutritional, and psychosocial risk factors for obesity and related disease in YupÕik people. The CANHR study was approved by the University of Alaska Institutional Review Board, the National and Area Indian Health Service Institutional Review Boards, and the Yukon-Kuskokwim Health Corporation Human Studies Committee. Between 2003 and 2006, 1003 men and women aged 14 and older were recruited from 10 communities in southwest Alaska, as described in detail elsewhere (19, 20) . At entry into the study, participants completed extensive interviewer-administered interviews covering demographic characteristics, economic status, ethnicity, and medical history. Anthropometric measurements were taken, and blood samples were collected from participants after an overnight fast. Blood was collected and processed locally into serum, lymphocyte, and RBC fractions using a portable centrifuge, and stored at 215°C in a portable freezer. Within 6 d, samples were shipped to the University of Alaska Fairbanks and stored at 280°C.
Study sample. Both d

15
N and RBC FA measurements were available for 496 participants from the CANHR study. The selection of these participants was described in detail elsewhere (6, 9) . We used this sample to compare associations of obesity and chronic disease risk factors with EPA, DHA, and d 15 N, and excluded 105 participants aged #18 y, 26 participants with CRP concentrations of >1 mg/dL (indicating acute infection), and 2 participants with missing body BMI measurements, which left 363 participants. Hereafter, we will refer to this sample as the ''validation sample.'' Stable isotope (d 15 N) measurements were available for all 1003 participants in the first phase of the CANHR study (CANHR 1). We used this larger sample to investigate associations between marine food intake (using d 15 N), obesity, and chronic disease risk, and excluded 178 participants aged #18 y, 51 participants with CRP concentrations of >1 mg/dL, and 2 participants with missing BMI measurements, leaving 772 participants. Hereafter, we will refer to this sample as the ''complete CANHR sample.'' Anthropometric and risk factor measurements. Anthropometric measurements, including height, weight, waist circumference, percentage of body fat, and blood pressure, were measured by trained staff using protocols from the NHANES III Anthropometric Procedures Manual (21), as described by Boyer et al. (22) . Biochemical risk factors for chronic disease were assayed in serum as previously described (9, 22 Statistical analyses. In the validation sample, we examined the associations of EPA, DHA, and d
N with each of the following measures of obesity: BMI, percentage of body fat, and waist circumference, and each of the following risk factors for chronic disease: systolic blood pressure (SBP), diastolic blood pressure (DBP), TGs, total cholesterol, HDL and LDL cholesterol, apo A-I, glucose, HbA1c, insulin, HOMA-IR, IGF-1, IGFBP-3, CRP, IL-6, sTNFR2, leptin, adiponectin, and ghrelin. TGs, insulin, HOMA-IR, CRP, IL-6, sTNFR2, and leptin were log transformed for analysis, and results were back transformed for ease of interpretation. We also examined associations of d
N with each of these variables in the complete CANHR sample, with the exception of IGF-1, IGFBP-3, IL-6, and sTNFR2, which were only available for the validation sample.
We excluded participants from certain analyses based on medication use (n = validation sample exclusions; complete CANHR sample exclusions). We excluded participants taking blood pressure medication from analyses of SBP and DBP (n = 62; 105), participants taking diabetes medication from analyses of glucose, HbA1c, insulin, and HOMA-IR (n = 7; 11), and participants taking cholesterol medication from analyses of TGs, total cholesterol, and HDL and LDL cholesterol (n = 18; 30).
Values of chronic disease risk factors that were >4 SD above the mean were judged to be physiologically unreasonable and excluded as outliers. We excluded values for the following chronic disease risk factors (n = validation sample exclusions; complete CANHR sample exclusions): waist circumference (n = 0; 1), SBP (n = 2; 4), DBP (n = 1; 1), TGs (n = 1; 4), total cholesterol (n = 0; 1), HDL (n = 1; 0), apo A-I (n = 2; 0), glucose (n = 2; 4), HbA1c (n = 3; 5), insulin (n = 0; 6), HOMA-IR (n = 0; 8), IL-6 (n = 0; 3), sTNFR2 (n = 2; 2), leptin (n = 0; 1), adiponectin (n = 1; 3), and ghrelin (n = 1; 3). For IL-6, values below the limit of detection (n = 91) were replaced by the limit of detection divided by the square root of 2 (25) .
We used multiple regression models to model associations of each biomarker (EPA, DHA, and d 15 N) with each measure of obesity or chronic disease risk factor. Models of obesity measures (BMI, percentage of body fat, and waist circumference) were adjusted for age (continuous), sex, and regular smoking (yes/no). All other models were additionally adjusted for BMI. A smaller number of the participants in the complete CANHR sample had physical activity data [counts per day: n = 249 (26) ]. In these participants, physical activity was not associated with d 15 N when adjusted for age, sex, BMI, and smoking (data not shown), nor was physical activity associated with any of the biochemical risk factors when adjusted for age, sex, BMI, smoking, and d N. Finally, we tested differences in the leptin: adiponectin ratio among quartiles of d
N using ANCOVA, with TukeyÕs honestly significant difference test for pairwise comparisons, adjusted for sex, age, BMI, and smoking. The leptin:adiponectin ratio was log transformed for analysis.
Both linear and quadratic terms were assessed to determine nonlinearity (8, 9, 24) . We used a conservative criterion (P < 0.01) for reporting quadratic associations because of the likelihood that multiple contrasts would lead to chance associations. For all tests, we give the unadjusted P value using a significance level of 0.05, and indicate in the text and tables whether P values remain significant after adjustment for multiple testing with the Bonferroni-Holm procedure (27) . Because BonferroniHolm adjusts the significance threshold (a) in a stepwise manner, a differs among tests within a family of hypotheses based on rank order. All statistical analyses were performed using JMP version 8 (SAS Institute).
Results
The demographic characteristics of the validation sample (n = 363) and the complete CANHR sample (n = 772) are given in Table 1 . Distributions of sex, BMI, and smoking were similar between the 2 samples; however, older participants ($55 y) were over-represented in the validation sample (28%) relative to the complete CANHR sample (21%). Younger participants (18-29 y) were under-represented (18% vs. 25% in the validation and complete CANHR samples, respectively).
The mean values of chronic disease risk factors for each study sample are shown in Table 2 . Means were generally similar between the 2 study samples, with the validation sample mean within 10% of the complete CANHR sample mean for most risk factors. Exceptions included insulin, HOMA-IR, and leptin, for which validation sample means exceeded those of the complete CANHR sample mean by 15%, 15%, and 17%, respectively, and CRP, for which the validation sample mean exceeded that of the complete CANHR sample by 88%. 15 N showed positive associations with total cholesterol, HDL and LDL cholesterol, apo A-I, and IGFBP-3, and an inverse association with TGs. All 3 measures had weak inverse associations with CRP, although only associations with EPA and DHA were significant (P = 0.027, 0.015, and 0.065 for EPA, DHA, and d 15 N, respectively). None of the measures were associated with BMI, body fat, waist circumference, SBP, DBP, blood glucose, insulin, HOMA-IR, IGF-1, and sTNFR2. The associations of d 15 N with total cholesterol and apo A-I became nonsignificant after adjustment for multiple testing, as did associations of EPA with HbA1c, IGFBP-3, and CRP, and associations of DHA with TGs, HDL cholesterol, IGFBP-3, and CRP. As expected, EPA exhibited more associations with chronic disease risk factors than DHA because DHA reaches an upper limit at high intakes. 
Discussion
This study compared associations with risk factors for chronic disease among 3 biomarkers of marine food intake measured in the RBCs of a YupÕik population: EPA, DHA, and d 15 N. Among these measures, EPA exhibited the most associations with chronic disease risk, followed by d 15 N, and finally DHA. Generally EPA and d 15 N had similar associations with chronic disease risk factors; however, associations with blood lipids and lipoproteins were stronger for EPA, whereas associations with d 15 N were stronger for adipokines (leptin and adiponectin), IL-6, and IGFBP-3. In the complete CANHR sample, d
15 N detected inverse associations with blood pressure and a positive quadratic association with adiponectin that were not previously detected in this population. d
15 N also revealed a weak positive association between traditional marine food intake and BMI in women. This study highlights the value of d 15 N as a practical measure for studying the associations between traditional marine food intake and chronic disease risk in YupÕik people, and improves our understanding of those relations. The systematic differences in chronic disease risk factor associations between d 15 N and EPA are interesting given the strong association (r > 0.8) between these measures in the YupÕik population (5, 6) . EPA, DHA, and high d
15 N values derive from traditional marine foods in this population; however, FAs (EPA, DHA) derive from the lipid portion of those foods, whereas marine protein (the source of elevated d 15 N) derives from the lean portion of those foods. We found that EPA was a more sensitive index related to associations of marine food intake with were excluded from calculations of means of blood pressure, blood lipid, and glucose homeostasis variables, respectively. 4 Variables were log transformed for analyses.
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blood lipid markers (e.g., HDL and LDL cholesterol, total cholesterol, TGs, and apo A-I), most likely because EPA has direct regulatory links to pathways involved in lipid metabolism (28) . However, there were other associations of chronic disease risk factors with marine food intake to which d 15 N was more sensitive, including hormones relating to adiposity, insulin sensitivity and energy balance (leptin, adiponectin, and ghrelin), IGFBP-3, and the inflammatory cytokine IL-6. This finding raises the possibility that nutrients deriving from the lean portion of the marine diet are more directly associated with these specific chronic disease risk factors. This suggestion is supported by a recent study showing that fish intake was more strongly associated with adiponectin than equivalent long-chain n-3 PUFA intake as fish oil (29) . These findings highlight the likelihood that multiple nutrients from traditional marine foods (fish and marine mammals) may be involved in chronic disease risk or protection, not simply EPA and DHA (30) .
Although the results of this study indicate differences between d
15 N and EPA in risk factor associations, these differences do not invalidate the use of d 15 N to evaluate associations between marine n-3 PUFA intake and chronic disease risk in YupÕik people. In the validation sample, d
15 N detected the same associations with blood lipids that EPA did, with the exception of the quadratic component of associations with total cholesterol and LDL cholesterol. However, in the larger, complete CANHR sample, d
15 N did detect quadratic associations with total cholesterol and HDL and LDL cholesterol, suggesting that d The associations of marine food intake with HDL cholesterol (+) and TGs (2) have been previously described for this population (9); however, by using d 15 N to assess relations with chronic disease risk factors in a larger sample, we also found new associations. d
15 N was negatively associated with both DBP and SBP, consistent with findings from other populations based on intake of fish oils (31) . d 15 N exhibited a strong positive quadratic association with adiponectin with an 18% increase between quartiles 3 and 4, suggesting that very high marine food intakes may be insulin-sensitizing and anti-inflammatory in this population (32) (33) (34) (35) (36) . Because d 15 N was also inversely associated with leptin, there was a marked decrease in the leptin:adiponectin ratio in the highest quartile of d 15 N. A low leptin:adiponectin ratio is associated with improved insulin sensitivity and endothelial function (32) , and is characteristic of lower risk of metabolic syndrome, independent of obesity (37, 38) . Thus, the association of high marine food intakes with adipokines may at UNIVERSITY OF CALIFORNIA DAVIS on April 9, 2015 jn.nutrition.org contribute to the low prevalence of type 2 diabetes in this (20) and other native Alaskan populations (39, 40) . Our data suggest that d 15 N may be a particularly sensitive and practical marker for these associations.
A weak positive association of d 15 N with BMI suggests a link between traditional marine food intake and obesity in women. Traditional YupÕik foods are high in fat and protein, and in a subset of the CANHR population (n = 531), self-reported fat intake increases from 32% to 44% of energy by quintile of traditional food intake (41) . A previous study found no relation between traditional food intake and energy intake (41); however, self-reported energy intake is particularly prone to bias and misreporting (42) , which could obscure a modest association. The mean BMI of women in the CANHR study is high (29.7 kg/m 2 ) (20) , and further investigation of the dietary factors contributing to obesity in YupÕik women is warranted.
This study has several key strengths and limitations. Intake of marine foods varies widely in the study population, creating an ideal scenario for testing associations of chronic disease risk factors with candidate biomarkers of marine food intake. However, biomarker-risk associations are likely to differ in populations with lower intakes of marine foods, and validation in a more representative population is required before applying d 15 N as a measure of marine food intake more broadly. The complete CANHR sample is large for a study using an objective dietary biomarker to examine diet-health relations, which gave us the power to detect new health benefits of traditional food intake. However, because this study is cross-sectional, we cannot determine causality or exclude the possibility of confounding from other dietary components or lifestyle factors (e.g., physical activity, which is known to influence HDL cholesterol) (43) . Traditional marine food intake is inversely associated with intake of market foods, including sugars (44) . A recent study from our group found associations of sugar intake with circulating lipids, blood pressure, adiponectin, and leptin that were the reverse of those described here (24) , and it is possible that covarying sugar intake may contribute to associations with chronic disease risk. However, associations of EPA and DHA intake with blood lipids and adipokine expression have strong a priori support (45, 46) , and the association of marine food intake with adiponectin has a different shape and a significantly higher magnitude compared with that of sugar intake with adiponectin (24) . Thus, we feel it is likely that marine food intake contributes significantly to these associations, particularly those with blood lipids and adipokines, but that further longitudinal studies will be needed to better clarify the contribution of specific nutrients to disease risk.
In summary, d
15
N shows similar associations with most chronic disease risk factors to RBC EPA and DHA. Associations with blood lipids and lipoproteins tended to be stronger with RBC EPA, whereas associations with blood pressure, adipokines, and Geometric means (95% CIs) are given for log-transformed variables. Slope of the regression model (b) is given as b 6 SE, or b (95% CI), where dependent variables were log transformed. CANHR, Center for Alaska Native Health Research; CRP, C-reactive protein; DBP, diastolic blood pressure; HbA1c, glycosylated hemoglobin A1c; SBP, systolic blood pressure. 2 Participants who reported taking blood pressure, cholesterol, or diabetes medication were excluded from analyses of blood pressure, blood lipid, and blood glucose/insulin variables, respectively. N is relatively simple and has high throughput, it is much more feasible to apply to larger studies than measurement of RBC FAs. When we used d 15 N to assay marine food intake in a larger YupÕik study population, we found new associations with blood pressure and adiponectin that were not previously detected. The finding with adiponectin is particularly significant because it may help to explain the low prevalence of type 2 diabetes in YupÕik people despite a high prevalence of obesity.
